George Adamis

789 total citations
9 papers, 117 citations indexed

About

George Adamis is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine and Infectious Diseases. According to data from OpenAlex, George Adamis has authored 9 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Critical Care and Intensive Care Medicine and 2 papers in Infectious Diseases. Recurrent topics in George Adamis's work include Sepsis Diagnosis and Treatment (3 papers), Parasite Biology and Host Interactions (2 papers) and Pneumonia and Respiratory Infections (2 papers). George Adamis is often cited by papers focused on Sepsis Diagnosis and Treatment (3 papers), Parasite Biology and Host Interactions (2 papers) and Pneumonia and Respiratory Infections (2 papers). George Adamis collaborates with scholars based in Greece, United States and Czechia. George Adamis's co-authors include Evangelos J. Giamarellos‐Bourboulis, Iraklis Tsangaris, Helen Giamarellou, Michael Chrisofos, Frantzeska Frantzeskaki, J. Kosmidis, Stefanos Atmatzidis, Maria Mouktaroudi, Maria Saridaki and Vasileios Lekakis and has published in prestigious journals such as International Journal of Molecular Sciences, International Journal of Antimicrobial Agents and Journal of Hospital Infection.

In The Last Decade

George Adamis

9 papers receiving 112 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Adamis Greece 6 72 32 16 15 15 9 117
В. В. Кулабухов Russia 7 51 0.7× 27 0.8× 18 1.1× 11 0.7× 18 1.2× 33 123
Ioannis Perdios Greece 3 70 1.0× 25 0.8× 14 0.9× 8 0.5× 13 0.9× 3 112
Elli Antypa Greece 5 78 1.1× 21 0.7× 59 3.7× 29 1.9× 14 0.9× 8 154
Haruhiko Ishioka Japan 9 27 0.4× 8 0.3× 6 0.4× 5 0.3× 43 2.9× 32 178
Morgan Walker United States 7 56 0.8× 13 0.4× 14 0.9× 8 0.5× 49 3.3× 24 131
Giacomo Guido Italy 6 20 0.3× 10 0.3× 6 0.4× 8 0.5× 39 2.6× 22 105
Ichiro Okada Japan 7 26 0.4× 19 0.6× 3 0.2× 11 0.7× 14 0.9× 29 128
Alicia Edin Sweden 7 80 1.1× 39 1.2× 14 0.9× 3 0.2× 16 1.1× 9 141
Ashok Mahashur India 9 46 0.6× 13 0.4× 4 0.3× 5 0.3× 27 1.8× 26 171
Chester Choi United States 6 92 1.3× 6 0.2× 12 0.8× 11 0.7× 40 2.7× 10 157

Countries citing papers authored by George Adamis

Since Specialization
Citations

This map shows the geographic impact of George Adamis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Adamis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Adamis more than expected).

Fields of papers citing papers by George Adamis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Adamis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Adamis. The network helps show where George Adamis may publish in the future.

Co-authorship network of co-authors of George Adamis

This figure shows the co-authorship network connecting the top 25 collaborators of George Adamis. A scholar is included among the top collaborators of George Adamis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Adamis. George Adamis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kyriazopoulou, Evdoxia, Georgia Damoraki, Panagiotis Koufargyris, et al.. (2025). Procalcitonin-guided early cessation of antibiotics prevents gut inflammation and preserves gut microbiome: Data from the PROGRESS controlled trial. International Journal of Antimicrobial Agents. 66(2). 107507–107507. 1 indexed citations
2.
Poulakou, Garyphalia, George Adamis, Aggeliki Rapti, et al.. (2022). Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19. International Journal of Molecular Sciences. 23(9). 4894–4894. 18 indexed citations
3.
Kyriazopoulou, Evdoxia, Athanasios Karageorgos, Panagiotis Koufargyris, et al.. (2021). BioFire® FilmArray® Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial. Infectious Diseases and Therapy. 10(3). 1437–1449. 18 indexed citations
4.
Kyriazopoulou, Evdoxia, et al.. (2017). Lipid peroxidation in Gram-negative bacteremia modulates the risk for septic shock and infections by resistant Klebsiella pneumoniae. European Journal of Clinical Microbiology & Infectious Diseases. 36(11). 2171–2177. 4 indexed citations
5.
Adamis, George, et al.. (2014). Candida blood steam infections: species distribution and antifungal resistance patterns. International Journal of Infectious Diseases. 21. 292–292. 1 indexed citations
6.
Tzanetou, Konstantina, et al.. (2010). Intestinal schistosomiasis caused by both Schistosoma intercalatum and Schistosoma mansoni. Travel Medicine and Infectious Disease. 8(3). 184–189. 9 indexed citations
7.
Giamarellos‐Bourboulis, Evangelos J., Iraklis Tsangaris, Maria Mouktaroudi, et al.. (2010). Procalcitonin as an early indicator of outcome in sepsis: a prospective observational study. Journal of Hospital Infection. 77(1). 58–63. 36 indexed citations
8.
Tzanetou, Konstantina, et al.. (2007). Urinary TractSchistosoma haematobiumInfection: A Case Report. Journal of Travel Medicine. 14(5). 334–337. 8 indexed citations
9.
Adamis, George, et al.. (2004). Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers. International Journal of Antimicrobial Agents. 23(2). 144–149. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026